🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study is to investigate the safety, tolerability, efficacy a...
Status
Completed
Location
1199.120.001 Boehringer Ingelheim Investigational Site
Start Date
2012-05
Trial ID
NCT01594125
This phase I, open label dose escalation study will investigate the additio...
Status
Terminated
Location
1199.117.003 Boehringer Ingelheim Investigational Site
Start Date
2011-04
Trial ID
NCT01329549
Phase I study. To determine the MTD (Maximum Tolerated Dose) of nintedanib ...
Status
Completed
Location
HOP d'Angers
Start Date
2016-03-07
Trial ID
NCT02668393
Treatments Being Tested
The purposes of this study are to: 1. evaluate potential interactions betw...
Status
Recruiting
Location
Research Site
Start Date
2026-04-28
Trial ID
NCT07454291
Treatments Being Tested
The objectives of this trial are to estimate the following in Japanese pati...
Status
Terminated
Location
1199.28.003 Boehringer Ingelheim Investigational Site
Start Date
2009-10-16
Trial ID
NCT00979576
The aim of this trial is to offer continuation of BIBF 1120 treatment for p...
Status
Completed
Location
INSARES
Start Date
2010-06-25
Trial ID
NCT01170065
The objective of the current study is to investigate the relative bioavaila...
Status
Completed
Location
1199.161.1 Boehringer Ingelheim Investigational Site
Start Date
2012-09
Trial ID
NCT01679613
Treatments Being Tested
The primary objective of this study is to evaluate PFS rate at 9 months of ...
Status
Completed
Location
1199.51.32002 Boehringer Ingelheim Investigational Site
Start Date
2009-05
Trial ID
NCT00904839
Treatments Being Tested
To confirm the safety of BIBF 1120 at a dose level up to 200 mg x 2/day (i....
Status
Completed
Location
1199.29.002 Boehringer Ingelheim Investigational Site
Start Date
2009-03
Trial ID
NCT00876460